Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets.
about
Vaccines and antiviral drugs in pandemic preparednessResistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsCurrent and future antiviral therapy of severe seasonal and avian influenzaLack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret modelAnimal models for influenza virus pathogenesis, transmission, and immunologyH1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural AnalysisInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistancePredicting 'airborne' influenza viruses: (trans-) mission impossible?Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spreadOseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferretsA mathematical framework for estimating pathogen transmission fitness and inoculum size using data from a competitive mixtures animal modelResistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivirIdentification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput ScreeningModel answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planningNew millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.Emergence of drug-resistant influenza virus: population dynamical considerations.A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistance.The effect of population structure on the emergence of drug resistance during influenza pandemics.Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08Mapping influenza transmission in the ferret model to transmission in humans.Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.Influenza A virus transmission: contributing factors and clinical implications.Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.Neuraminidase inhibitor sensitivity and receptor-binding specificity of Cambodian clade 1 highly pathogenic H5N1 influenza virusEffect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 virusesThe ferret as a model organism to study influenza A virus infection.The pathogenesis of influenza virus infections: the contributions of virus and host factorsThe global spread of drug-resistant influenza.Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferretsCombination chemotherapy for influenza.The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.Fitness of neuraminidase inhibitor-resistant influenza A virusesConsequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitorPhenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors
P2860
Q22305646-5297AA4B-1BE0-487C-87E3-6CBAEF04E0EFQ22305941-C0949F1D-900C-4C11-A5D1-61A2AC1503EEQ24656164-8D562C05-46ED-43B5-9A77-47404F9EAF81Q24670511-9432C64B-E47F-4ACD-A276-66208A7F08E7Q27024582-2F93E148-A008-44B7-9A71-084F071ED901Q27673887-E0F6A965-517C-40F7-B8B9-0BF923979AC4Q28282405-972C875A-54B6-475E-9A82-F5C08F03C2C7Q28382815-3C88BD61-5185-435A-8F29-984A7B2ACFECQ28471814-8208CC26-D0B3-4D96-BEBF-5EF6430EEBD8Q28474960-32A39714-A586-44BF-A9F0-1B46585B781CQ28477927-DDA819A0-28F0-4FE3-A1D6-4494A98FF74EQ28535274-EE8EB66C-F440-40BA-8F5B-01AA550E77AFQ28830304-A80E081D-B7C9-4143-B9B1-409977E2E945Q30230076-26C64A8E-8374-40C5-8115-35463CDCDFBAQ30332341-4050FFF0-C42B-483A-8753-6AFFC2E0AAD4Q30353989-52BC2B28-4DDF-428F-B4E3-C96759DE1612Q30357193-3BF2C03A-C987-4991-9751-25656EC9B5C1Q30362753-CDB9764B-D581-4146-A44E-364F115799A6Q30364619-9F2DC1D2-F486-42B6-A927-C18C0EB5FA49Q30371242-BDF75F03-B634-461C-B369-BC07678336FBQ30374475-F499AB1B-93C3-4838-AB9C-89FF0D29B347Q30374740-AE1B3A98-1CC3-4367-B7B0-50CD26039157Q30378661-AE1D2ACD-CDBB-468D-A3D4-656DEEF4C343Q30386485-8D748050-7D5B-4F62-B931-88740E6B7DCBQ30397203-F54CA41F-6E99-4EF9-BC26-F9306670BE34Q30398271-CF2E470F-4208-41A7-8F33-F851912C789FQ30400058-C37B076F-2686-4D43-BD15-D431B799F8B8Q30400680-0F0CD9BA-1968-4A2B-AE3A-0235E6A95116Q30405589-52362D0E-6A16-45AE-B503-36183C03EA59Q30405941-33466CDD-3BF7-4FF8-A04D-17451465EE71Q30406360-B5F80217-F2CC-46B6-8897-BECE04593B04Q30407925-91B85D16-7D0F-4A45-ACB5-DDDF614FBF66Q30408112-4D4F3C9C-9CE5-4FE3-86E6-202BB10CD2C7Q30410229-D1C60F6C-3F36-4E2E-A069-4DE4B400637DQ30414559-2097E824-C312-4308-BC29-E18A1C5B138CQ30425354-8FCC3009-FDB9-4C59-8B80-8E64C6C67EE9Q30438502-46D6A132-CE13-4759-A03E-94DC0E8D22D9Q30445738-43A0BDF8-A107-414D-8C21-37B71E70BE50Q30448118-4A3529EA-9E70-482D-BEE3-71F330C7759AQ30450742-B8E8967C-6192-4F0A-9AEB-F67C622CC59E
P2860
Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Influenza virus carrying an R2 ...... is not transmitted in ferrets.
@en
type
label
Influenza virus carrying an R2 ...... is not transmitted in ferrets.
@en
prefLabel
Influenza virus carrying an R2 ...... is not transmitted in ferrets.
@en
P2093
P1433
P1476
Influenza virus carrying an R2 ...... is not transmitted in ferrets.
@en
P2093
Herlocher ML
P304
P356
10.1016/S0166-3542(01)00214-5
P577
2002-05-01T00:00:00Z